Comparing two methods for preparing the uterus for frozen embryo transfer in women with adenomyosis
Official title: The Effectiveness of the Two Different Endometrial Preparation Regimes for Frozen Embryo Transfer in Patients With Adenomyosis
Run by Mỹ Đức Hospital · NCT06239376 · Data updated 2026-11-12
This study tests two different ways to prepare the uterus for frozen embryo transfer in women with adenomyosis to see which one helps achieve more successful pregnancies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 222 (estimated) |
| Sponsor | Mỹ Đức Hospital Academic / other |
| Locations | 1 site (Ho Chi Minh City, Ho Chi Minh City) |
| Status | Recruiting |
| Started | February 19, 2024 |
| Main results expected | April 15, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT06239376 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 to 42 with a confirmed diagnosis of adenomyosis who are preparing for frozen embryo transfer.
✕Probably not a fit
Patients with uterine abnormalities or contraindications to hormone therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of two different endometrial preparation protocols for frozen embryo transfer (FET) in women diagnosed with adenomyosis. Participants will be randomly assigned to receive either a regimen that includes a GnRH agonist and letrozole or a standard protocol using exogenous steroids alone. The study aims to determine which approach leads to higher live birth rates and to assess the side effects associated with the GnRH agonist treatment. The trial is designed to provide insights into optimal treatment strategies for improving reproductive outcomes in this patient population.
Why it matters
Potential benefit: If successful, this study could improve live birth rates for women with adenomyosis undergoing frozen embryo transfer.
How similar studies have gone: There have been no randomized controlled trials specifically investigating these endometrial preparation protocols in women with adenomyosis, making this approach novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirm diagnosis with adenomyosis by using transvaginal ultrasonography (MUSA consensus) and/or pelvic magnetic resonance imaging. * Age between 18 - 42 * Undergo less or equal to three previous IVF cycles * Indicate for frozen embryo transfer * Agree to have not more than two day-3 embryo or one blastocyst (day-5 and day-6) transferred * Not participating in any other study Exclusion Criteria: * Embryos from IVM cycle * Having uterine or adnexal abnormalities (e.g., intrauterine adhesions, unicornuate/ bicornuate/ arcuate uterus; unremoved hydrosalpinx, endometrial polyp, submucosal leiomyoma, or leiomyoma with endometrial cavity distortion) * Having contraindications for exogenous hormones administration: breast cancer, risks of venous thromboembolism * Embryos from the oocyte donation cycle. * Patients with a history of GnRH injection within three months, measured from the last GnRHa injection to the study screening date.
Where it's running
-
My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam Recruiting
Study contacts
- Principal investigator: Lan N Vuong, MD, PhD — University of Medicine and Pharmacy at Ho Chi Minh City
- Study coordinator: Tien K Le, MD
- Email: bstien.lk@myduchospital.vn
- Phone: +84962803875
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
G-CSF for DOR in women undergoing IVF
This trial tests whether G-CSF shots can improve IVF outcomes for women with diminished ovarian reserve.
-
Dual Trigger vs HCG Trigger for Final Maturation in Normal Responders
In normal responders undergoing ICSI cycles, this study tests whether using a dual trigger (GnRH agonist plus hCG) improves outcomes compared with the standard hCG trigger.
-
Cannabinoid-based product for gynecologic pain in endometriosis, adenomyosis, or PID
This study tests a high-CBD, hemp-derived product against placebo in adults with gynecologic pain from endometriosis, adenomyosis, or PID over one week to see if it reduces pain and related symptoms.
-
Pentoxifylline to improve uterine lining and frozen embryo transfer outcomes
This trial sees if giving pentoxifylline alongside standard estradiol helps women with good-quality day‑5 frozen embryos get a thicker uterine lining and better frozen embryo transfer success.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
-
Aromatherapy to support mental health in women undergoing IVF
This will test whether inhaling lavender oil twice daily can reduce anxiety, stress, and depression and improve quality of life for women awaiting IVF.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.